Compounds > plusbacin a3

Page last updated: 2024-08-04 07:51:44

plusbacin a3

Description

plusbacin A3: inhibits peptidoglycan synthesis in Staphylococcus aureus [MeSH]

Cross-References

ID Source	ID
PubMed CID	168315246
MeSH ID	M0396976

Synonyms (1)

Synonym
plusbacin a3

Research

Studies (5)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	5 (100.00%)	84.16%

Substance	Studies	Classes	Roles	First Year	Last Year	Average Age	Relationship Strength	Trials	pre-1990	1990's	2000's	2010's	post-2020
cyanides	1	pseudohalide anion	EC 1.9.3.1 (cytochrome c oxidase) inhibitor	2018	2018	6.0	medium	0	0	0	0	1	0
hexafluoroisopropanol	1	organofluorine compound; secondary alcohol	drug metabolite	2018	2018	6.0	medium	0	0	0	0	1	0
vancomycin	2	glycopeptide	antibacterial drug; antimicrobial agent; bacterial metabolite	2001	2007	20.0	medium	0	0	0	2	0	0
acetylglucosamine	1	N-acetyl-D-glucosamine	epitope	2001	2001	23.0	medium	0	0	0	1	0	0
deuterium	1	dihydrogen		2017	2017	7.0	medium	0	0	0	0	1	0
glycidyl nitrate	3			2001	2017	13.7	high	0	0	0	1	2	0
katanosin b	1			2001	2001	23.0	medium	0	0	0	1	0	0

Condition	Indicated	Studies	First Year	Last Year	Average Age	Relationship Strength	Trials	pre-1990	1990's	2000's	2010's	post-2020
Bacterial Disease	0	1	2013	2013	11.0	high	0	0	0	0	1	0
Bacterial Infections	0	1	2013	2013	11.0	high	0	0	0	0	1	0
Infections, Staphylococcal	0	1	2013	2013	11.0	high	0	0	0	0	1	0
Staphylococcal Infections	0	1	2013	2013	11.0	high	0	0	0	0	1	0

chemdatabank.com